Skip to main content
. Author manuscript; available in PMC: 2006 Jul 11.
Published in final edited form as: Curr Eye Res. 2005 Jul;30(7):505–515. doi: 10.1080/02713680590968637

TABLE 1.

Development of Antimicrobial Peptides as Anti-Infective Drugsa

Advantages
 Broad-spectrum activity (antibacterial, antiviral, antifungal)
 Rapid onset of killing
 Cidal activity
 Potentially low levels of induced resistance
 Concomitant broad anti-inflammatory activities
Disadvantages
 Discovery costs of synthesis and screening
 Patent exclusivity for economic viability
 Systemic and local toxicity
 Reduced activity based on salt, serum, and pH sensitivity
 Susceptibility to proteolysis
 Pharmacokinetic (PK) and pharmacodynamic (PD) issues
 Sensitization and allergy after repeated application
 Natural resistance (e.g., Serratia marcescens)
 Confounding biological functions (e.g., angiogenesis)
 High manufacturing costs
a

Refs. 21, 32, 33.